Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00887380
What this trial is testing

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

Who this might be right for
Breast Cancer
Trans Tasman Radiation Oncology Group 2,023
Large-scale testing (Phase 3)Study completedNCT00000559
What this trial is testing

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseHeart Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Study completedNCT04629846
What this trial is testing

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

Who this might be right for
Breast Cancer
Qilu Pharmaceutical Co., Ltd. 517
Large-scale testing (Phase 3)Looking for participantsNCT06530459
What this trial is testing

The MUSE Study for Menopausal Arthralgia

Who this might be right for
ArthralgiaMenopausePerimenopausal Disorder+2 more
National University Hospital, Singapore 100
Testing effectiveness (Phase 2)Study completedNCT02971761
What this trial is testing

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Who this might be right for
Androgen Receptor PositiveEstrogen Receptor NegativeHER2/Neu Negative+3 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00661531
What this trial is testing

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

Who this might be right for
Breast CancerCancer of the BreastNeoplasms, Breast
Georgetown University 11
Early research (Phase 1)Ended earlyNCT01149356
What this trial is testing

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+4 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT00830973
What this trial is testing

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

Who this might be right for
Breast NeoplasmsTamoxifen
Medco Health Solutions, Inc. 184
Very early researchStudy completedNCT03599453
What this trial is testing

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple -Negative Breast CancerEstrogen Receptor NegativeHER2/Neu Negative+2 more
Roswell Park Cancer Institute 8
Not applicableStudy completedNCT00114270
What this trial is testing

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

Who this might be right for
Breast CancerOsteoporosis
University of Virginia
Early research (Phase 1)UnknownNCT05673694
What this trial is testing

To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Changchun GeneScience Pharmaceutical Co., Ltd. 70
Post-approval studies (Phase 4)Study completedNCT03336437
What this trial is testing

Estrogen and the Urogenital Microbiome in GSM

Who this might be right for
Menopause
Oregon Health and Science University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04821141
What this trial is testing

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Who this might be right for
Risk ReductionBreast Cancer
University of Kansas Medical Center 120
Not applicableStudy completedNCT00301353
What this trial is testing

Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women

Who this might be right for
Osteoporosis
TNO 300
Testing effectiveness (Phase 2)Ended earlyNCT01126801
What this trial is testing

Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women

Who this might be right for
Menopausal Depression
Massachusetts General Hospital 2
Large-scale testing (Phase 3)Study completedNCT00687102
What this trial is testing

Cognition in the Study of Tamoxifen and Raloxifene

Who this might be right for
CognitionAging
Wake Forest University 1,498
Testing effectiveness (Phase 2)Ended earlyNCT03284957
What this trial is testing

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 136
Not applicableWithdrawnNCT01200537
What this trial is testing

Optimizing Ovulation Induction in the Poor Responder

Who this might be right for
IVF Poor Responders
Duke University
Not applicableStudy completedNCT03437837
What this trial is testing

Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Who this might be right for
Breast CancerNeoadjuvant TherapyNeoplasm Staging+5 more
Peking University First Hospital 1,077
Early research (Phase 1)Study completedNCT04176757
What this trial is testing

ZN-c5 in Participants With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 35
Next Page